| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2024―May―14 |
Bioinformatics Study of Flavonoids From Genus Erythrina As Ace2 inhibitor Candidates For Covid-19 Treatment |
Tati Herlina, Abd Wahid Rizaldi Akili, Vicki Nishinarizki, Ari Hardianto, Jalifah Latip |
| 2 |
[GO] |
2023―Jan―18 |
In silico Screening of Potential SARS-CoV-2 Main Protease Inhibitors from Thymus schimperi |
Hylemariam Mihiretie Mengist, Zunera Khalid, Fentahun Adane |
| 3 |
[GO] |
2022―Aug―15 |
In silico Drug Repurposing of Anticancer Drug 5-FU and Analogues Against SARS-CoV-2 Main Protease: Molecular Docking, Molecular Dynamics Simulation, Pharmacokinetics and Chemical Reactivity Studies |
Aristote Matondo, Washington Dendera, Bienfait Kabuyaya Isamura, Koto-te-Nyiwa Ngbolua, Hilaire VS Mambo, Mayaliwa Muzomwe, Virima Mudogo |
| 4 |
[GO] |
2022―Aug―02 |
Multi Epitope-Based Vaccine Design for Protection Against Mycobacterium tuberculosis and SARS-CoV-2 Coinfection |
Dian Ayu Eka Pitaloka, Afifah Izzati, Siti Amirah, Luqman Abdan Syakuran |
| 5 |
[GO] |
2022―Jun―15 |
Comparative Structural Analysis of Human ACE2 Receptor with Spike Protein of SARS-CoV-2 Variants: Implications to Understand Infectivity of the Virus |
Tirthankar Koley, Arunima Goswami, Manoj Kumar, Neelam Upadhyay, Gururao Hariprasad |
|
